佰泽医疗（02609.HK）：2月9日南向资金增持217.74万股

Core Viewpoint - Southbound funds have increased their holdings in Baize Medical (02609.HK) by 2.17 million shares on February 9, 2026, indicating growing investor interest in the company [1]. Group 1: Shareholding Changes - In the last 5 trading days, Baize Medical has seen a net increase of 3.31 million shares from southbound funds over 2 days [1]. - Over the past 20 trading days, there have been 11 days of net increases, totaling 7.16 million shares [1]. - As of February 9, 2026, southbound funds hold 74.80 million shares of Baize Medical, representing 5.66% of the company's total issued ordinary shares [1]. Group 2: Trading Data - On February 9, 2026, the total shareholding was 74.80 million, with a change of 2.17 million shares, reflecting a 3.00% increase [2]. - On February 6, 2026, the total shareholding was 72.63 million, with a decrease of 0.36 million shares, showing a -0.50% change [2]. - On February 5, 2026, the total shareholding was 72.99 million, with a decrease of 0.70 million shares, indicating a -0.96% change [2]. - On February 4, 2026, the total shareholding was 73.70 million, with a decrease of 0.84 million shares, reflecting a -1.13% change [2]. - On February 3, 2026, the total shareholding was 74.54 million, with an increase of 3.04 million shares, showing a 4.26% change [2]. Group 3: Company Overview - Baize Medical Group is primarily engaged in investment and provision of medical-related services, focusing on oncology [2]. - The company offers comprehensive oncology services, including screening, diagnosis, treatment, and rehabilitation [2]. - Its business operations include hospital services, hospital management, supply of pharmaceuticals, medical devices, and consumables, as well as other health management services [2].